The fact that gal-3 deficiency-induced asymmetric growth restriction followed by relatively rapid catch-up growth is of significant importance since human babies with these characteristics, particularly those with accelerated postnatal weight gain after in utero growth restriction, have a greatly enhanced risk of developing type 2 diabetes, obesity and cardiovascular disease25–27. Here, LGALS3 is linked to type 2 diabetes mellitus.